Study of INV-202 in Patients With Obesity and Metabolic Syndrome

NCT05891834 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

243

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Metabolic Syndrome

Interventions

DRUG: INV-202
DRUG: Placebo

Sponsor

Inversago Pharma Inc.